Tag
A blind patient with Stargardt disease regained the ability to read a letter after receiving the PRIMA implant in a clinical trial, showing promise for treating this form of blindness.
A new wearable headset by Flow Neuroscience is now available in the US for treating depression, offering low-intensity electrical stimulation to the brain as an alternative to medication.
MIT Lincoln Laboratory's AI-GUIDE, a portable AI-powered medical device for vascular access, has won the 2026 Excellence in Technology Transfer Award and is being commercialized to improve survival rates in trauma care.
Abbott has received FDA authorization for the Libre Duo, the first continuous glucose monitor that measures both glucose and ketone levels to help prevent diabetic ketoacidosis. The device is designed to provide early warnings for ketone buildup in diabetic patients.
This commemorates the 40th anniversary of catheter ablation, highlighting Dr. Melvin Scheinman's contributions to this medical procedure.
A blood drawing machine has been introduced in China, designed to automate the process of collecting blood samples for medical purposes.
MIT engineers have developed a tiny ingestible capsule that can continuously measure core body temperature with high accuracy, enabling improved health monitoring in various applications such as infection detection and fever tracking.
The FDA has authorized the first wearable device that continuously monitors both ketone and blood sugar levels, helping people with diabetes detect dangerous complications early.
The tweet highlights a Chinese-made patient transfer bed with one-touch remote control that reduces physical strain for patients.
A Japanese company called Iris has developed Nodoca, an AI-powered device that analyzes throat images to diagnose influenza in seconds, eliminating uncomfortable nasal swabs. Already approved in Japan and used at over 2,000 institutions, it is expanding to detect other conditions like Covid-19 and potentially lifestyle diseases.
The Verge reviews CipherX's Microdot patches, a new pain-free permanent tattooing technology that uses microscopic biodegradable needles to deposit pigment, potentially making tattoos available by mail.
Johnson & Johnson received marketing authorization for its robotic surgery device, entering the US market.
A device called the Eye-in-a-Care-Box (ECaBox) can revive eyes from dead donors by perfusing them with oxygen-rich fluid, preserving retinal function and potentially enabling whole-eye transplants.
French startup Tissium has developed a liquid biopolymer that uses light to attach to severed nerves, acting as a biodegradable splint to improve healing. The treatment is now available in the US and has shown promising results in early trials.
Researchers at MIT have developed PlasmoSniff, a breath test that uses nanoparticles and enhanced Raman spectroscopy to detect pneumonia and other lung conditions in minutes, potentially enabling rapid at-home or clinical diagnosis.
Dr. Matthew Zirwas retracts his earlier dismissal of the Midjourney ultrasound scanner, acknowledging that if it is high-resolution, harmless, inexpensive, and convenient, frequent screening could overcome historical pitfalls of unnecessary invasive procedures, though he emphasizes that data is needed to confirm benefit.
A 60-second ultrasound-based full-body scanner that outperforms MRI.
A new 15-minute at-home tick test kit called LymeAlert, developed by an MIT-trained physician assistant, aims to quickly detect Lyme disease bacteria from ticks to enable early antibiotic treatment and reduce unnecessary doctor visits.
China has approved the world's first invasive brain-computer chip, NEO, for use beyond clinical trials, marking a major step in the country's ambition to lead in brain implant technology.
China has approved the world's first invasive brain-computer interface (BCI) product, NEO, developed by Neuracle Technology and Tsinghua University, for use in patients with paralysis from spinal cord injuries, marking a significant milestone in neurotechnology.